Back to All Speakers

Thomas J. Glynn, PhD

Adjunct Lecturer, Stanford Prevention Research Center, Stanford University School of Medicine

If you are a smoker, no matter what your age or how long you have been smoking, the best time to quit is now.

Dr. Glynn is Adjunct Lecturer, Stanford Prevention Research Center, Stanford University School of Medicine. From 1998 to 2014, he was Director, Cancer Science and Trends and Director, International Cancer Control at the American Cancer Society (ACS). In these positions, he advised the ACS about emerging research and policy issues in cancer prevention and control, recommended cancer prevention and control research and policy which is ready for national application, and participated in the development of an international cancer control program aimed at promoting cancer prevention-related research, advocacy, treatment, and policy change, particularly in middle- and low-income nations.

Prior to coming to the ACS, Dr. Glynn was, from 1991 to 1994, Associate Director of the U.S. National Cancer Institute’s (NCI) Cancer Control Science Program and, from 1991 to 1998, Chief of the NCI’s Cancer Control Extramural Research Branch. There, he directed the development of a national program of research aimed at reducing the incidence and prevalence of cancer, primarily through dietary change, tobacco use reduction, and adherence to cancer screening guidelines. From 1983 to 1991, he was Research Director for the NCI’s Smoking, Tobacco, and Cancer Program.

Dr. Glynn has published widely on cancer and tobacco use prevention and control, both in the scientific literature and for consumer, professional, and patient education. He was recently editor of an ACS monograph series on advocacy for policy change in tobacco control and, during his NCI tenure, was co-developer of the 4A (now 5A) protocol for the treatment of tobacco dependence. In addition to his work at the ACS and NCI, he has served as a consultant on cancer control and tobacco issues to such groups as the National Academy of Sciences/Institute of Medicine, the National Research Council, the Robert Wood Johnson Foundation, a variety of pharmaceutical organizations, and state and local governments. He has also served as a Senior Scientific Reviewer for the U.S. Surgeon General’s Reports on Tobacco and Health, as Director of the World Health Organization Study of Health, Economic, and Policy Implications of Tobacco Growth and Consumption in Developing Countries, and has been active in tobacco control programs in Eastern Europe, Central America, and India. His awards include the U.S. National Institutes of Health Merit Award, the Polish Ministry of Health Service Award, the Guatemala National Council for Tobacco Prevention and Control Meritorious Service Award, the Society for Research on Nicotine and Tobacco John Slade Award, and the American Society of Preventive Oncology Joseph W. Cullen Memorial Award.

Previous Sessions

Monday, May 21, 2018

Tobacco Use and Treatment Through the Lifespan – an Overview

Tuesday, May 22, 2018

Implementation: Adapting treatment models for medical setting: Evolution of the five A’s

Monday, May 23, 2016

Panel: Global Context of Tobacco Dependence Treatment

The panel of international tobacco control experts discuss challenges faced by many countries in the implementation of tobacco dependence treatment, and the importance of tobacco dependence treatment as part of comprehensive tobacco control. The panel shares their perspectives on the interrelationships and synergy between tobacco dependence treatment and other components of comprehensive tobacco control.